Top

Cannvas Adds Cannabis & Science Module to Cannvas.Me Education Platform – Exploring the Scientific Complexities of Cannabis

Cannvas Adds Cannabis & Science Module to Cannvas.Me Education Platform – Exploring the Scientific Complexities of Cannabis

TORONTO, Oct. 25, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM), a leader in digital cannabis education and leading business technology company, is pleased to announce the addition of the Cannabis and Science module to the Cannvas.Me education platform, where those curious about the scientific complexities of cannabis can explore and learn about strains, the chemical makeup of the plant, and how the active compounds in cannabis make it a potential benefit to a healthy lifestyle.

“I have always been interested in the science of cannabis and how the different strains produce different effects depending how they are used and who uses them,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “Our Cannabis & Science module takes a closer look into this miraculous plant to discover its unique properties. There are many documented benefits of using medical cannabis for certain illnesses, and we want to explore and discover the science behind those therapeutic benefits.”

The Cannvas.Me Cannabis & Science module is for active and potential cannabis users interested in learning more about the science of the plant and how it impacts the human endocannabinoid system. Whether users have questions about cannabinoids, endocannabinoids, or phytocannabinoids, or are curious about the differences between tetrahydrocannabinol, cannabidiol or terpenes, the Cannabis & Science module explores all aspects of the cannabis plant and how it interacts with the human body. As with all Cannvas.Me modules, the Cannabis & Science module is overseen by the Cannvas.Me Medical Advisory Board and Educational Advisory Panel to ensure all information presented is relevant, accurate and timely.

Canada is leading the transformation of the cannabis world through legalization and through the emergence of an influential and powerful industry. Cannvas is committed to bring high quality education and information to Canada and around the world to ensure proper use and promote the benefits of cannabis. Additional relevant modules and tools will be added to the platform as they become available.

Cannvas.Me is an unbiased educational resource for medicinal and adult-use cannabis users. It is a comprehensive solution for the global cannabis community offering innovative tools and physician-backed content to all audiences wishing to learn about health care through cannabis. The education platform utilizes machine-learning algorithms and artificial intelligence (AI) to contextualize and adapt as users navigate the website, to ensure a best-in-class experience for all using the most accurate and up-to-date information.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc.

For further information: www.cannvasmedtech.com, Media Inquiries: media@cannvasmedtech.com, Investor Relations: ir@cannvasmedtech.com, 1-800-489-0116

Related Links

https://cannvasmedtech.com

X